1. 2902 GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation. (September 2015) Authors: Sepúlveda, J.M.; Vaz, M.A.; Gil, M.; Reynés, G.; Gallego, O.; Bolós, M.V.; Laýn, A. Hernádez; Sánchez-Gómez, P.; Martýnez, M.; Vicente, E.; Quindos, M.; Luque, R.; Ramos, A.; Ruano, Y.; Manneh, R.; Segura, P. Pérez; Benavides, M.; Balañá, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma. (1st November 2018) Authors: Prieto‐Barrios, M.; Llamas‐Martin, R.; Velasco‐Tamariz, V.; Calleja‐Algarra, A.; Ruano, Y.; Ortiz‐Romero, P.L.; Rodriguez‐Peralto, J.L. Journal: British journal of dermatology Issue: Volume 179:Number 5(2018) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma. (9th May 2018) Authors: Prieto‐Barrios, M.; Llamas‐Martin, R.; Velasco‐Tamariz, V.; Calleja‐Algarra, A.; Ruano, Y.; Ortiz‐Romero, P.L.; Rodriguez‐Peralto, J.L. Journal: British journal of dermatology Issue: Volume 179:Number 5(2018) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗